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The synapse is the site of a remarkable conversion of electrical signals into chemical signals. 
This conversion takes place when a depolarizing impulse enters the axon terminal and opens volt-
age-sensitive calcium channels; calcium then flows into the cell and initiates the fusion of synaptic 
vesicles with the plasma membrane. The precise mechanisms of synaptic vesicle dynamics remains a 
mystery. We would like to understand the specialized molecular machinery that is required to dock 
and prepare vesicles for release, fuse the vesicular and plasma membranes, and finally to recycle 
vesicular components to regenerate mature synaptic vesicles. 
We are identifying proteins involved in neurotransmission using a genetic strategy to analyze 
the nematode C. elegans. There are aspects of this nematode that make it well-suited for studies of 
the nervous system. First, the nervous system in C. elegans is largely nonessential under laboratory 
conditions. Although the two sexes can mate to produce hybrid progeny, the hermaphrodite can fer-
tilize her eggs internally in the absence of males (Wood, 1988). For this reason coordinated locomo-
tion is not required for mating. Second, since the nematode is maintained on a lawn of bacteria, it 
does not need to search for its food. Ingestion of bacteria is mediated by the pharynx. Because con-
tractions of the pharyngeal muscle can be driven by myogenic action potentials, food intake can oc-
cur even with a severely defective nervous system (Avery & Horvitz, 1989). For these reasons, 
mutants with severe defects in neurotransmission can be propagated and studied. Nevertheless, 
some nervous function is required for survival since the absence of acetylcholine or the death of cer-
tain neurons will cause the animal to die (Avery & Horvitz, 1989; Rand, 1989). 
A second advantage to using C. elegans for these studies arises from our detailed knowledge of 
the nervous system. The number of neurons is invariant among individuals: there are 302 neurons 
with fixed positions in the adult animal (Sulston & Horvitz, 1977). In addition, the connectivity of 
the nervous system has been reconstructed from serial electron micrographs (White, Southgate, 
Thomson & Brenner, 1986). Because C. elegans is transparent, identified neurons can be killed with 
a laser microbe am and changes in behavior analyzed in a living animal (Chalfie, Sulston, White, 
Southgate, Thomson & Brenner, 1985; Avery & Horvitz, 1989). These behavioral abnormalities in 
conjunction with the known connectivity of the nervous system can be used to deduce the function 
of a particular neuron in the context of a simple circuit. Finally, the spectrum of neurotransmitters 
used by C. elegans is essentially the same as in other animals, and many of the pharmaceuticals that 
have been characterized in vertebrates act similarly in nematodes (Lewis, Wu, Levine & Berg, 1980; 
Horvitz, Chalfie, Trent, Sulston & Evans, 1982; Avery & Horvitz, 1990; McIntire, Jorgensen, 
Kaplam & Horvitz, 1993b). These drugs can then be used to characterize existing mutants or to iso-
217 
218 Erik M. Jorgensen el 01. 
late new mutants in genetic screens. 
We have pursued two classes of genes required for neurotransmission: genes required for the 
functioning of a single neurotransmitter, specifically, the neurotransmitter GABA, and genes re-
quired for the functioning of all neurotransmitters. The critical step in obtaining mutations in these 
processes is the design of an appropriate genetic screen. We discuss three screens designed to obtain 
mutants in these processes. We then describe the phenotype of animals with mutations in the synap-
tic vesicle protein synaptotagmin and propose that this protein functions in the regeneration of syn-
aptic vesicles. 
GENES REQUIRED FOR GADA FUNCTION 
Any given neuromuscular junction will require two kinds of proteins: those that mediate synap-
tic functions common to all synapses, such as the proteins required for synaptic vesicle exo- and en-
docytosis, and the proteins required for the specific neurotransmitter used by that synapse. These 
neurotransmitter-specific proteins would include proteins required for the selection of a proper syn-
aptic partner, the biosynthetic enzymes for the neurotransmitter, the transporters that pump the 
neurotransmitter through the plasma and vesicular membranes, and the receptors and receptor-as-
sembly proteins in the post synaptic cell. 
We are identifying the proteins required for the functioning of the neurotransmitter gamma 
aminobutyric acid (GABA). GABA is the main inhibitory neurotransmitter in both vertebrates and 
invertebrates. We have undertaken a cellular, genetic, and molecular analysis of GABA neurotrans-
mission in C. efegans. We have two goals: first, we would like to know how the GABAergic neu-
rons function in the context of a known circuit; and second we would like to use the knowledge 
gained about the circuit to identify the molecules that are required specifically for GABA transmis-
sion. Our strategy consists of the following steps. First, we identified the GABAergic neurons in the 
nematode using immunohistochemistry. Second, we killed these cells to characterize their roles in 
the control of C. efegans behavior. Third, we are identifying genes that function in GABA transmis-
sion by looking for mutants that behave similarly to the operated animals. 
Staining worms with an anti-GABA antibody demonstrated that of the 302 neurons in C. efe-
gans, 26 express the neurotransmitter GABA (Fig. I, McIntire, Jorgensen & Horvitz, 1993a). We 
killed these cells using a laser microbeam and identified functions for 25 of these 26 neurons (McIn-
tire et af. 1993a). GABA functions can be classified as either inhibitory or excitatory based on the 
effect of GABA on muscle contractions. 
Inhibitory GABA Function: The DD and VD GABAergic motor neurons provide contralateral 
inhibition to antagonistic muscle groups, that is, they insure that if one side of the body is contract-
ed, the other side is relaxed so that the animal can bend in a coordinated fashion while swimming. 
Lack of these cells causes animals to hypercontract or "shrink" when they are touched (Fig. 2). The 
RME motor neurons synapse to the anterior body muscles and are required to dampen the oscilla-
tions of the head and nose as the animal forages. 
Excitatory GAB A Function: The A VL and DVB neurons innervate the enteric muscles that 
compress the intestine and open the anus. Animals lacking the A VL and DVB neurons lack contrac-
tions of the enteric muscles. GABA is usually an inhibitory neurotransmitter that acts by opening 
anion channels. However, GABA appears to drive contractions in these muscles by an alternative 
mechanism indicating a novel excitatory action of GABA. This conclusion is supported by the con-
nectivity of these neurons and by our pharmacological and genetic data. First, the A VL and DVB 
neurons directly innervate the enteric muscles and appear to be the only motor neurons forming 
neuromuscular junctions with these muscles. Second, GAB A agonists can induce contractions of 
the enteric muscles in the absence of innervation from A VL and DVB, but the GABA drugs that 
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Fig. 1. GABA immunoreactivity in C. efegans 
Fluorescent photomicrograph and a tracing of a wild-type adult hermaphrodite stained with an an-
tiserum raised against GABA. The 26 neurons stained with the anti-GABA antiserum are indicat-
ed (McIntire et af. 1993). Anterior is to the right, and dorsal is up. The pharynx is indicated by the 
dotted line. 
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affect muscle contraction are different from the ones causing the body muscles to relax. Third, gene 
products required for muscle relaxation (unc-49) and muscle contraction (exp-l) are different (see 
below). These gene products are required postsynaptically and presumably encode two different 
GABA receptors. 
By screening for mutants that display the shrinking defect (Fig. 2; McIntire et al. 1993b) or the 
expulsion defect (Jorgensen & Horvitz, unpublished), we identified six genes required specifically 
for either the inhibitory or the excitatory functions of GABA as well as genes required for all 
GABA functions (Table 1). 
One of these genes, unc-25, encodes the biosynthetic enzyme for GABA, glutamic acid decar-
boxylase (Y. Jin & H.R. Horvitz, unpublished data). unc-30 encodes a homeodomain protein that 
is required for normal connectivity of and GABA expression in the DD and VD GABAergic neu-
rons (Jin, Hoskins & Horvitz, 1994). unc-49 is required postsynaptically and encodes a GABAA-like 
receptor (B. Bamber & E. Jorgensen, unpublished data). unc-46 and unc-47 are required for all 
GABA functions and appear to encode presynaptic proteins. exp-l is required only for the 
postsynaptic excitatory GABA function (Jorgensen & Horvitz, unpublished results) and may there-
fore encode a novel receptor. 
Table 1. Genes required for GABA function 
gene inhib. fx excit. fx 
unc-25 + + 
unc-30 + 
unc-46 + + 
unc-47 + + 
unc-49 + 
exp-l + 





Fig. 2. Loss of GABAergic function causes hypercoutraction of the body muscles 
A. A model for 00 and VO neuronal function (McIntire et ul. 1993). The excitatory motor neu-
rons (VA. VB, OA, and AS) excite the body muscles (shaded) and activate the GABAergic 00 or 
VO neurons, which cause relaxation of the dorsal and ventral muscles, respectively. Locomotory 
behavior (B) in a wild-type animal and (C) in an unc-25 (e/56) mutant, which lacks GABA expres-
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GENES REQUIRED FOR THE FUNCTIONING OF ALL SYNAPSES 
All neuromuscular junctions must possess the machinery that converts an electrical signal into 
the secretion of neurotransmitters contained in synaptic vesicles. The components required for syn-
aptic vesicle dynamics might be shared by multiple transmitters include cytoskeletal proteins that 
maintain the reserve pool of vesicles, voltage-sensitive calcium channels, vesicle docking and fusion 
proteins, and finally proteins required for the recycling and regeneration of vesicles. We used a 
genetic strategy to identify mutants that lacked normal synaptic function. These mutants will be 
used to characterize the genes and gene products required for synaptic function. We used two 
screens to identify synaptic function mutants: a screen for mutants that behaved as if they lacked 
acetylcholine and GABA neurotransmission and a selection for mutants that failed to release neu-
rotransmitter. 
1. Behavioral screen 
We used our knowledge about neurotransmitters in C. eiegans to identify genes required for 
the functioning of all synapses. The cha-l gene encodes the biosynthetic enzyme choline acetyltrans-
ferase, and cha-l mutants lack acetylcholine (Rand & Russell, 1984). Such animals display a dis-
tinctive locomotory defect: they have jerky movements and often coil when moving backward. unc-
25 mutants, which lack GABA, as described above, shrink and lack contractions of the enteric mus-
cles. Double mutants have an additive phenotype. Animals lacking normal synaptic transmission be-
cause of defects in neurotransmitter release would be expected to display all of these defective be-
haviors. By screening mutagenized animals for this combined mutant phenotype, we identified 14 
mutations that defined 11 complementation groups (Table 2). To confirm that there was a decrease 
in released acetylcholine in these mutants, we demonstrated that they were resistant to an inhibitor 
of acetylcholinesterase (see below). Alleles of many of the genes identified in this screen had been 




unc-41 n2163, n2913 






unc-l n2887 dm, n2918 dm 
unc-68 n2226 sd 
ric-6 n2915 sd 
snt, synaptotagmin; unc, uncoordinated; ric, resistant to inhibitors of 
cholinesterase. - - - - -
sion (McIntire et al. 1993). The head of each animal was touched with a platinum wire. Touch to 
the head of the wild-type animal resulted in backward movement characterized by deep sinusoidal 
waves. Touch to the head of the unc-25 mutant caused the ventral and dorsal muscles to contract 
simultaneously, resulting in no backward movement and a shrinkage of body length. 
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identified previously by Sydney Brenner (1974), who isolated many mutants that could not move 
normally and named these genes after this uncoordinated phenotype, Vnc. Two of the genes iden-
tified in our screen, ric-6 and ric-7, represent previously unidentified loci, demonstrating that 
screens for such loci are not yet saturated. Of the genes we identified, only unc-J3 and snt-l have 
been characterized at a molecular level. unc-13 encodes a large protein with a phorbol ester-binding 
domain (CI) and a calcium-binding domain (C2) (Maruyama & Brenner, 1991). Although the 
domain structure of the VNC-13 protein is provocative, the precise role of this protein in synaptic 
function is still unknown. snt-l encodes the synaptic vesicle protein synaptotagmin (Nonet, Grun-
dahl, Meyer & Rand, 1993). We have used our synaptotagmin mutant to characterize the function 
of this protein in the synapse (see below). 
2. A screen for letbal mutations that disrupt synaptic transmission 
The behavioral screen for transmission mutants described above has two disadvantages. First, 
it is laborious: behavioral screens require that each mutagenized animal be observed before it can 
be selected as a candidate for further characterization. Second, the screen will miss genes that are 
mutated to lethality, since the screen requires homozygous mutants to survive until adulthood. 
Mutations in genes that are required for neurotransmission may be lethal for two reasons: (1) 
Mutants lacking all nervous system function are lethal. Mutants lacking acetylcholine (cha-l 
mutants synthesize no acetylcholine) die as coiled Ll larvae (Rand & Russell, 1984). Also, animals 
in which the M4 pharyngeal motor neuron or the CAN neurons have been killed also die (Avery & 
Horvitz, 1989; Manser & Wood, 1990). (2) Some of the components of the synaptic vesicle fusion 
complex may also be components of the exocytotic machinery of all cells (Bennett & Scheller, 1993); 
eliminating such gene products would generate an inviable animal because of defective secretion in 
non-neuronal cells. 
We have devised a selection that circumvents these drawbacks. First, by using a pesticide that 
kills wild-type animals we performed a selection for neurotransmission mutants instead of a screen 
for behavioral defects. Acetylcholine transmission is terminated when the neurotransmitter is 
cleaved by the enzyme acetylcholinesterase. Inhibitors of acetylcholinesterase, such as the pesticide 
aldicarb, cause toxic levels of acetylcholine to build up in the synaptic cleft of nematodes (Rand & 
Russell, 1985). In the presence of the drug, the body muscles hypercontract, the pharynx is para-
lyzed and the animal eventually dies. Mutations in some genes encoding synaptic components 
reduce the release of neurotransmitter into the synaptic cleft and thereby confer resistance to these 
drugs (Brenner, 1974; Alfonso, Grundahl, Duerr, Han & Rand, 1993; Gengyo-Ando, Kamiya, 
Yamakawa, Kodaira, Nishiwaki, Miwa, Hori & Hosono, 1993; Nonet et al. 1993). For example, 
mutants that fail to release acetylcholine because they fail to synthesize the neurotransmitter (cha-l) 
or fail to package the neurotransmitter into vesicles (unc-l7) are resistant to aldicarb (Alfonso et al. 
1993; Alfonso, Grundahl, McMaus & Rand, 1994). 
Second, by performing the selection in a sensitized background we can isolate homozygous 
lethal mutations in heterozygous viable animals. Specifically, when the mutation unc-13(n28J3) is 
homozygous (genotype: unc-13/unc-J3) the strain is strongly resistant to aldicarb (Fig. 3). When 
this mutation is heterozygous (genotype: unc-J3/ +) the strain is sensitive to the drug. This geno-
type represents our sensitized background in which heterozygous mutations at a second locus can 
be isolated. For example, mutations in a single copy of the gene encoding synaptotagmin (geno-
type: snt-J/ +; unc-13/ +) make our sensitized strain aldicarb-resistant. This synthetic drug 
resistance was observed in double mutants with several genes known to be involved in neurotran-
smission (snt-l, unc-41, and unc-32). Thus, in the screen we simply looked for new aldicarb 
resistant mutants in this sensitized background (Fig. 3). Based on the results of the reconstruction 
experiments described above, we should be able to isolate more alleles of homozygous viable muta-
tions like snt-l and unc-41. In addition, because these newly-induced mutations can be complement-
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most animals are aldicarb-sensitive: 
+ unc-13(n2813) 
+ 
--- . , ----I ..... DEAD 
+ 
rare mutants are aldicarb-resistant: 
.. new AldR • unc-13(n2813) 
, --I ...... ALIVE 
+ + 
Fig. 3. Selection for mutations that enhance aldicarb resistance in an unc-J3/ + sensitized back-
ground (see text) 
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ed by the wild-type chromosome, we hoped to recover lethal mutations that enhance drug 
resistance. 
We screened 2,300 Fl animals (2,300 genome equivalents) and isolated 123 synthetic aldicarb-
resistant strains. Given that known uncoordinated mutants exhibit drug resistance, we expected to 
isolate viable uncoordinated strains. As expected we isolated many such strains (about half of our 
strains, Table 3). Most of these strains were either coilers or inactive animals with a weak jerky 
backing phenotype-precisely the behavioral phenotypes observed in existing aldicarb-resistant 
strains. Although the genetic characterization of these mutants has only just begun, we recovered 
mutations in unc-26 and in unc-2, genes known to mutate to aldicarb-resistance (E. Jorgensen, un-
published data). These results demonstrated that the screen successfully isolated new aldicarb-
resistant mutations. 
Some resistant mutations after separation from the unc-13 mutation led to a behaviorally wild-
type phenotype. It is known that mutants in at least one protein associated with synaptic vesicles, 
rab3a, are aldicarb-resistant but have no known behavioral abnormality (M. Nonet, personal com-
munication). Therefore, such mutations were also expected. 
Table 3. Mutations isolated in synthetic aldicarb-resistance selection 
phenotype 




sterile uncoordinated adults 
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Of our aldicarb-resistant mutants, 62 segregated either inviable or sterile adults. Although 
these strains have not been outcrossed, the lethal phenotype segregates with that of the aldicarb-
resistance. Thus, we expect that the lethal mutation confers aldicarb-resistance to these strains and 
that it is not a second unrelated mutation in the background of the strain. These lethal mutations 
could not have been isolated in screens for homozygous mutants and are precisely the kind of muta-
tions we had hoped to obtain. Future characterization of these strains may demonstrate that these 
gene products are components of the secretion machinery in neuronal and non-neuronal cells. 
SYNAPTOTAGMIN 
One of the eleven genes identified in our behavioral screen, snt-/, was shown by others to en-
code synaptotagmin (Nonet et al. 1993). Synaptotagmin is an integral membrane protein of the syn-
aptic vesicle (Matthew, Tsavaler & Reichardt, 1981; Perin, Fried, Mignery, Jahn & Siidhof, 1990) 
and interacts with proteins of the plasma membrane (Bennett, Calakos, Kreiner & Scheller, 1992; 
Leveque, Hoshino, David, Shoji-Kasai, Leys & Omori, 1992; Hata, Davletov, Petrenko, Jahn & 
Siidhof, 1993). Because it binds calcium (Brose, Petrenko, Siidhof & Jahn, 1992), synaptotagmin 
has been proposed to be the calcium sensor that regulates exocytosis at the synaptic terminal. Two 
divergent models have been suggested regarding synaptotagmin function: synaptotagmin could 
either facilitate or inhibit synaptic vesicle release (Popov & Poo, 1993). Both of these models impli-
cate a role for synaptotagmin in exocytosis. By contrast, our results suggest that synaptotagmin is 
required in the recycling of vesicles. We propose that synaptotagmin is a multifunctional protein 
that acts in both exocytosis and the regeneration of synaptic vesicles. 
We inferred a role for synaptotagmin in the retrieval of vesicular components from an ultras-
tructural characterization of the mutant synapse. First, we examined electron micrographs of snt-/ 
mutants and found that the density of synaptic vesicles at the neuromuscular junctions in these 
mutants is severely depleted (Fig. 4). Second, we demonstrated that the vesicles were generated nor-
mally at the cell body in the mutant and that vesicle components were transported to the neuromus-
cular junction. Specifically, we examined a double mutant containing defects in snt-/ and unc-104, 
a gene encoding a neural-specific kinesin. In the double mutant, vesicles were observed in the cell 
body, since in the absence of kinesin the vesicles accumulated in the axon hillock. Furthermore, 
fluorescently-Iabelled synaptobrevin, a vesicular component, was transported to neuromuscular 
junctions in the mutant as in the wild type (K. Schuske & E. Jorgensen, unpublished data). Because 
a severe depletion of vesicles was observed by electron microscopy it is likely that the synaptic vesi-
cle components have been displaced into the plasma membrane. Third, pharmacological experi-
ments indicated that there is a decrease in neurotransmitter release. Specifically, synaptotagmin 
mutants were resistant to inhibitors of cholinesterase, suggesting that there is a decrease in released 
neurotransmitter. This drug resistance argues against a model in which the depletion of vesicles is 
caused solely by constitutive secretion, because unregulated release of neurotransmitter presumably 
would lead to a hypersensitivity to inhibitors of cholinesterase. Taken together, these results indi-
cate that the defect seen in snt-/ mutants is caused primarily by a defect in the endocytotic retrieval 
of vesicles. Recently, it has been shown that synaptotagmin is the clathrin-AP2 receptor in the plas-
ma membrane of rat neurons (Zhang, Davletov, Siidhof & Anderson, 1994), providing further evi-
dence that synaptotagmin plays a role in endocytosis and vesicular recycling. This conclusion does 
not preclude synaptotagmin from playing a role in exocytosis-only that the primary defect seen in 
the C. elegans snt-/ mutant is at the step of vesicular recycling. We suggest that synaptotagmin 
plays a role in the regulation of exocytosis, as demonstrated by others, and that this protein also 
acts to identify components of synaptic vesicles in the plasma or endosomal membrane and mark 
them for retrieval and for the regeneration of mature vesicles. 
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Fig. 4. Synaptic vesicles are depleted at neuromuscular junctions in snt-l mutants 
A, Electron micrograph of a wild-type neuromuscular junction. Large arrow, dark thickening of 
an active zone. Arrowhead, one synaptic vesicle. 
B, Electron micrograph of a snt-l(md290) neuromuscular junction. 
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